Jane Street Group, LLC Autolus Therapeutics PLC Transaction History

Jane Street Group, LLC

$384 Billion
Q1 2025

A detailed history of Jane Street Group, LLC transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Jane Street Group, LLC holds 102,493 shares of AUTL stock, worth $155,789. This represents 0.0% of its overall portfolio holdings.

Number of Shares

102,493

Previous 102,493 -0.0%

Holding current value

$155,789

Previous $158,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$1.55 - $2.68 $141,394 - $244,474	91,222 Added 809.35%	102,493 $158,000
Q4 2024 Feb 14, 2025	BUY	$2.18 - $4.8 $24,570 - $54,100	11,271 New	11,271 $26,000
Q2 2024 Aug 14, 2024	BUY	$3.33 - $5.68 $58,711 - $100,144	17,631 Added 23.31%	93,275 $324,000
Q1 2024 May 15, 2024	BUY	$5.39 - $7.29 $43,923 - $59,406	8,149 Added 12.07%	75,644 $482,000
Q4 2023 Feb 14, 2024	BUY	$2.13 - $6.63 $113,961 - $354,724	53,503 Added 382.38%	67,495 $434,000
Q3 2023 Nov 14, 2023	SELL	$2.32 - $3.36 $21,513 - $31,157	-9,273 Reduced 39.86%	13,992 $32,000
Q2 2023 Aug 14, 2023	SELL	$1.64 - $3.21 $119,082 - $233,081	-72,611 Reduced 75.73%	23,265 $55,000
Q1 2023 May 15, 2023	BUY	$1.75 - $2.25 $167,783 - $215,721	95,876 New	95,876 $176,000
Q3 2022 Nov 14, 2022	BUY	$2.04 - $3.76 $9,326 - $17,190	4,572 Added 31.07%	19,289 $41,000
Q2 2022 Aug 16, 2022	BUY	$2.04 - $4.68 $30,022 - $68,875	14,717 New	14,717 $42,000
Q1 2022 May 17, 2022	SELL	$3.52 - $5.46 $46,999 - $72,901	-13,352 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$5.1 - $7.0 $68,095 - $93,464	13,352 New	13,352 $69,000
Q3 2021 Nov 16, 2021	SELL	$5.32 - $7.37 $157,408 - $218,063	-29,588 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$4.78 - $7.96 $141,430 - $235,520	29,588 New	29,588 $196,000
Q3 2020 Nov 17, 2020	SELL	$11.64 - $16.3 $158,187 - $221,517	-13,590 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$5.38 - $16.14 $73,114 - $219,342	13,590 New	13,590 $218,000

Others Institutions Holding AUTL

# of Institutions

100

Shares Held

163M

Call Options Held

Put Options Held

88.3K

View Full List

About Autolus Therapeutics plc

Ticker AUTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,909,800
Market Cap $138M
Description
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...

More about AUTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Autolus Therapeutics PLC Transaction History